Ketamine, esketamine, and ECT can rapidly ease suicidal thoughts, but evidence for preventing attempts or deaths remains limited—see what’s proven.
|Articles|May 25, 2023
What Have You Heard About 988?
Author(s)Psychiatric Times Editors
988 has been around for almost a year now. What have you heard about its efficacy?
Advertisement
As we approach the 1-year anniversary of the launch of 988, which we covered in our
Have you discussed 988 with your patients?
Have your patients used 988?
If you/your patients have any experiences, we want to hear about them! Please reach out at
Advertisement
Related to this article
Learn how clozapine, lithium, ketamine, and antidepressants fit into suicide prevention, from rapid crisis relief to long-term risk reduction.
Can hormones flag suicide risk in schizophrenia? Review links cortisol, thyroid and testosterone shifts—and clozapine/lithium pathways—to risk.
How VA clinicians treat veterans’ PTSD while managing suicide risk, using shared decisions, safety planning, and phase-based trauma therapies.
Advertisement
Advertisement
Trending on Psychiatric Times
1
Defining Treatment-Resistant Depression In Adults
2
Interventional Options for TRD: ECT, TMS, and Esketamine
3
AI as a Task-Replacing Tool for Psychiatric Care: A Conversation With Christoph Correll, MD
4
Post Hoc SOLARIS Data Support Stabilization and Remission With Subcutaneous Olanzapine
5